301015.SZ SHZ
Qingdao Baheal Medical Inc.
1W: -2.8%
1M: +4.6%
3M: +26.6%
YTD: +7.5%
1Y: +2.8%
3Y: +2.9%
¥25.68 ($3.83)
+0.64 (+2.56%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$7.1B
+10.8% ▲
5Y CAGR: +15.7%
Total Liabilities
$4.5B
+36.7% ▲
5Y CAGR: +16.2%
Shareholders Equity
$2.4B
-17.9% ▼
5Y CAGR: +13.1%
Cash & Investments
$1.5B
+10.2% ▲
5Y CAGR: +5.4%
Total Debt
$2.3B
+59.1% ▲
5Y CAGR: +11.4%
Net Debt
$846M
+668.5% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $1.1B | $1.3B | $1.0B | $1.3B | $1.5B |
| Short-Term Investments | $35M | $41M | $84M | $28M | $45M |
| Cash & ST Investments | $1.1B | $1.3B | $1.1B | $1.4B | $1.5B |
| Net Receivables | $1.7B | $2.0B | $2.2B | $2.4B | $2.4B |
| Inventory | $610M | $624M | $650M | $862M | $928M |
| Other Current Assets | $4 | $166M | $300M | $308M | $82M |
| Total Current Assets | $3.5B | $4.1B | $4.3B | $5.1B | $5.1B |
| Property, Plant & Equip. | $221M | $226M | $433M | $395M | $811M |
| Goodwill & Intangibles | $37M | $35M | $57M | $105M | $340M |
| Long-Term Investments | $199M | $152M | $237M | $264M | $698M |
| Other Non-Current Assets | $14M | $66M | $8M | $489M | $95M |
| Total Non-Current Assets | $509M | $511M | $857M | $1.3B | $2.0B |
| Total Assets | $4.1B | $4.6B | $5.1B | $6.4B | $7.1B |
| — Liabilities — | |||||
| Accounts Payable | $843M | $846M | $990M | $408M | $1.2B |
| Short-Term Debt | $1.3B | $1.2B | $1.2B | $574M | $1.1B |
| Deferred Revenue | $109M | $114M | $92M | $0 | $0 |
| Other Current Liabilities | $210M | $15M | $235M | $1.1B | $219M |
| Total Current Liabilities | $2.5B | $2.4B | $2.6B | $2.4B | $3.3B |
| Long-Term Debt | $0 | $0 | $0 | $772M | $1.1B |
| Other Non-Current Liab. | $0 | $0 | $0 | $0 | $5M |
| Total Non-Current Liabilities | $40M | $28M | $232M | $906M | $1.2B |
| Total Liabilities | $2.6B | $2.4B | $2.8B | $3.3B | $4.5B |
| — Equity — | |||||
| Common Stock | $472M | $525M | $525M | $526M | $526M |
| Retained Earnings | $697M | $1.1B | $1.2B | $1.4B | $1.5B |
| Accumulated OCI | $92M | $2M | $143M | $271M | $301M |
| Total Stockholders Equity | $1.5B | $2.2B | $2.3B | $2.9B | $2.4B |
| Total Liabilities & Equity | $4.1B | $4.6B | $5.1B | $6.4B | $7.1B |
| — Key Metrics — | |||||
| Total Debt | $1.4B | $1.2B | $1.3B | $1.5B | $2.3B |
| Net Debt | $243M | -$50M | $290M | $110M | $846M |
| Total Investments | $234M | $152M | $321M | $263M | $743M |